| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013807 |
| Receipt No. | R000015336 |
| Official scientific title of the study | Long-term Effect of Tolvaptan Administration for Outcome and Neurohormonal Factors in Patients with Heart Failure |
| Date of disclosure of the study information | 2014/04/25 |
| Last modified on | 2017/07/23 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Long-term Effect of Tolvaptan Administration for Outcome and Neurohormonal Factors in Patients with Heart Failure | |
| Title of the study (Brief title) | Clinical Effect of Long-term Tolvaptan Administration | |
| Region |
|
|
| Condition | ||
| Condition | heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the clinical effect of long-term Tolvaptan administration in patients with heart failure with fluid retention. Especially, to examine the effects of neurohormonal factors and renal function. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The changes in neurohormonal factors (catecholamine, renin activity, aldosterone, copeptin) |
| Key secondary outcomes | The finding of fluid retention, the changes in serum sodium, BUN, Cr, urinary L-FABP, dosage of diuretics, blood pressure, heart rate and 6-month prognosis (readmission and death) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Assigned following 2 groups, when heart failure treatment is hemodynamically stable.
TLV group: Add on tolvaptan (1.875mg/day to 15mg/day) with conventional diuretics for 6 months. |
|
| Interventions/Control_2 | Conventinal diuretics group: Treat with conventional diuretics except tolvaptan for 6 months. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Heart failure in-hospital patients with fluid retention
Required continuous diuretics treatment |
|||
| Key exclusion criteria | Patients with a history of hypersensitivity for tolvaptan or an analogue.
Anuresis or hypernatremia. Patients who have difficulty with fluid intake or can not feel dipsesis. Pregnant woman or possibility of the pregnancy. Patients whom tolvaptan is already given at registration. Patients whom study responsibility physician judged inappropriate. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Kiyoshi Iida |
| Organization | Nihon University Surugadai Hospital |
| Division name | Department of Cardiology |
| Address | 1-8-13 Kanda-Surugadai, Chiyoda, Tokyo |
| TEL | 03-3293-1711 |
| kiida2830@jcom.home.ne.jp | |
| Public contact | |
| Name of contact person | Kiyoshi Iida |
| Organization | Nihon University Surugadai Hospital |
| Division name | Department of Cardiology |
| Address | 1-8-13 Kanda-Surugadai, Chiyoda, Tokyo |
| TEL | 03-3293-1711 |
| Homepage URL | |
| kiida2830@jcom.home.ne.jp | |
| Sponsor | |
| Institute | Nihon University Surugadai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 駿河台日本大学病院(東京都)、日本大学板橋病院(東京都)、聖路加国際病院(東京都)、三井記念病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015336 |